PURE Bioscience Welcomes New Members to Board of Directors and Scientific Advisory Board
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced the addition of three new members to the Board of Directors with the election of Kristin A. Taylor, David M. Rendall and Tom Myers. Ms. Taylor and Mr. Rendall also will serve on the audit and compensation committees of the Board of Directors. PURE also is pleased to announce the appointment of Dr. Scott Harris and Dr. Ma
